Mitsubishi UFJ Trust & Banking
IONS icon

Mitsubishi UFJ Trust & Banking’s Ionis Pharmaceuticals IONS Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
+13,446
New +$1.01M ﹤0.01% 832
2021
Q4 		– Sell
-50
Closed -$2K – 1371
2021
Q3 		$2K Hold
50
– – ﹤0.01% 1369
2021
Q2 		$2K Sell
50
-79,901
-100% -$3.13M ﹤0.01% 1365
2021
Q1 		$3.6M Sell
79,951
-16,458
-17% -$918K 0.01% 747
2020
Q4 		$5.45M Sell
96,409
-294,697
-75% -$14.7M 0.01% 731
2020
Q3 		$18.6M Sell
391,106
-73,769
-16% -$4.1M 0.04% 417
2020
Q2 		$27.4M Sell
464,875
-2,855
-0.6% -$159K 0.07% 308
2020
Q1 		$22.1M Sell
467,730
-5,546
-1% -$309K 0.06% 312
2019
Q4 		$28.6M Sell
473,276
-2,235
-0.5% -$133K 0.07% 322
2019
Q3 		$28.5M Sell
475,511
-29,577
-6% -$1.93M 0.07% 301
2019
Q2 		$32.5M Buy
505,088
+134,918
+36% +$9.54M 0.11% 225
2019
Q1 		$30M Sell
370,170
-1,840
-0.5% -$119K 0.11% 224
2018
Q4 		$20.1M Sell
372,010
-7,400
-2% -$377K 0.08% 272
2018
Q3 		$19.6M Buy
379,410
+6,790
+2% +$319K 0.07% 326
2018
Q2 		$15.5M Buy
372,620
+115,810
+45% +$5.13M 0.03% 613
2018
Q1 		$11.3M Sell
256,810
-102,940
-29% -$5.23M 0.02% 667
2017
Q4 		$18.1M Sell
359,750
-9,230
-3% -$506K 0.03% 563
2017
Q3 		$18.7M Sell
368,980
-610
-0.2% -$32K 0.03% 533
2017
Q2 		$18.8M Sell
369,590
-8,000
-2% -$373K 0.04% 522
2017
Q1 		$15.2M Sell
377,590
-14,100
-4% -$633K 0.03% 576
2016
Q4 		$18.7M Buy
391,690
+3,870
+1% +$153K 0.04% 496
2016
Q3 		$14.2M Sell
387,820
-258,339
-40% -$8.08M 0.03% 571
2016
Q2 		$15M Buy
646,159
+87,377
+16% +$2.82M 0.03% 545
2016
Q1 		$22.6M Buy
558,782
+6,939
+1% +$282K 0.05% 411
2015
Q4 		$34.2M Sell
551,843
-3,818
-0.7% -$206K 0.08% 291
2015
Q3 		$22.5M Buy
555,661
+331,553
+148% +$17.2M 0.05% 387
2015
Q2 		$12.9M Sell
224,108
-3,678
-2% -$234K 0.03% 595
2015
Q1 		$14.5M Buy
+227,786
New +$15.5M 0.03% 552

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's IONS Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 13,446 shares worth $1.07M. The stake represents ﹤0.01% of the portfolio and ranks #832 among its holdings. This is a return to the name: Mitsubishi UFJ Trust & Banking previously reported a position in IONS as recently as Q3 2021.

Mitsubishi UFJ Trust & Banking first reported a position in IONS in Q1 2015 and has held it in 28 quarters since. The position peaked at $34.2M in Q4 2015. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 13,446 shares of Ionis Pharmaceuticals worth $1.07M as of Q2 2026.
  • Ionis Pharmaceuticals was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #832 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in Ionis Pharmaceuticals in Q1 2015 and has held it in 28 quarters since.
  • Mitsubishi UFJ Trust & Banking's Ionis Pharmaceuticals position peaked at $34.2M in Q4 2015.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.